Literature DB >> 29101413

The gestational power of mast cells in the injured tissue.

Maria-Angeles Aller1, Natalia Arias2,3, Vicente Martínez4, Patri Vergara4,5, Jaime Arias6.   

Abstract

The inflammatory response expressed after wound healing would be the recapitulation of systemic extra-embryonic functions, which would focus on the interstitium of the injured tissue. In the injured tissue, mast cells, provided for a great functional heterogeneity, could play the leading role in the re-expression of extra-embryonic functions, i.e., coelomic-amniotic and trophoblastic-vitelline. Moreover, mast cells would favor the production of a gastrulation-like process, which in certain tissues and organs would induce the regeneration of the injured tissue. Therefore, the engraftment of mesenchymal stem cells and mast cells, both with an extra-embryonic regenerative phenotype, would achieve a blastema, from the repaired and regenerated injured tissue, rather than by fibrosis, which is commonly made through wound-healing.

Entities:  

Keywords:  Amnion; Embryonic; Mast cells; Mesenchymal stem cells; Regeneration; Wound healing; Yolk sac

Mesh:

Year:  2017        PMID: 29101413     DOI: 10.1007/s00011-017-1108-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  67 in total

Review 1.  Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems.

Authors:  M A Aller; J L Arias; M P Nava; J Arias
Journal:  Exp Biol Med (Maywood)       Date:  2004-02

Review 2.  Preservation solutions used during abdominal transplantation: Current status and outcomes.

Authors:  Nicholas Latchana; Joshua R Peck; Bryan A Whitson; Mitchell L Henry; Elmahdi A Elkhammas; Sylvester M Black
Journal:  World J Transplant       Date:  2015-12-24

Review 3.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 4.  Mast cell, the peculiar member of the immune system: A homeostatic aspect.

Authors:  György Csaba
Journal:  Acta Microbiol Immunol Hung       Date:  2015-09       Impact factor: 2.048

Review 5.  Inflammation as an animal development phenomenon.

Authors:  Gustavo Campos Ramos
Journal:  Clin Dev Immunol       Date:  2011-10-19

Review 6.  Salamander regeneration as a model for developing novel regenerative and anticancer therapies.

Authors:  Jonathan Fior
Journal:  J Cancer       Date:  2014-09-20       Impact factor: 4.207

Review 7.  Mast cells: from lipid droplets to lipid mediators.

Authors:  Andrea Dichlberger; Petri T Kovanen; Wolfgang J Schneider
Journal:  Clin Sci (Lond)       Date:  2013-08       Impact factor: 6.124

Review 8.  Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases.

Authors:  Ivana Antonucci; Martina Provenzano; Melissa Rodrigues; Andrea Pantalone; Vincenzo Salini; Patrizia Ballerini; Cesar V Borlongan; Liborio Stuppia
Journal:  Int J Mol Sci       Date:  2016-04-22       Impact factor: 5.923

Review 9.  Chronic inflammatory systemic diseases: An evolutionary trade-off between acutely beneficial but chronically harmful programs.

Authors:  Rainer H Straub; Carsten Schradin
Journal:  Evol Med Public Health       Date:  2016-01-27

Review 10.  Mast Cell: A Multi-Functional Master Cell.

Authors:  Melissa Krystel-Whittemore; Kottarappat N Dileepan; John G Wood
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

View more
  1 in total

Review 1.  Preparation of placental tissue transplants and their application in skin wound healing and chosen skin bullous diseases - Stevens-Johnson syndrome and toxic epidermal necrolysis treatment.

Authors:  Agnieszka Klama-Baryła; Ewa Rojczyk; Diana Kitala; Wojciech Łabuś; Wojciech Smętek; Katarzyna Wilemska-Kucharzewska; Marek Kucharzewski
Journal:  Int Wound J       Date:  2020-01-15       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.